Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Gene targeting MRI: nucleic acid-based imaging and applications.

Liu PK, Liu CH.

Methods Mol Biol. 2011;711:363-77. doi: 10.1007/978-1-61737-992-5_18.

PMID:
21279612
2.

Transcription MRI: a new view of the living brain.

Liu PK, Mandeville JB, Guangping Dai, Jenkins BG, Kim YR, Liu CH.

Neuroscientist. 2008 Oct;14(5):503-20. Review.

PMID:
18024855
3.
4.

Targeting nucleic acids into mitochondria: progress and prospects.

Niazi AK, Mileshina D, Cosset A, Val R, Weber-Lotfi F, Dietrich A.

Mitochondrion. 2013 Sep;13(5):548-58. doi: 10.1016/j.mito.2012.05.004. Review.

PMID:
22609422
5.

Oligonucleotide-mediated gene targeting in human hepatocytes: implications of mismatch repair.

Igoucheva O, Alexeev V, Anni H, Rubin E.

Oligonucleotides. 2008 Jun;18(2):111-22. doi: 10.1089/oli.2008.0120.

6.
7.

Nanotechnology: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2006;6(19):1-43.

8.

American Medical Society for Sports Medicine position statement: concussion in sport.

Harmon KG, Drezner JA, Gammons M, Guskiewicz KM, Halstead M, Herring SA, Kutcher JS, Pana A, Putukian M, Roberts WO.

Br J Sports Med. 2013 Jan;47(1):15-26. doi: 10.1136/bjsports-2012-091941. Review. Erratum in: Br J Sports Med. 2013 Feb;47(3):184.

PMID:
23243113
9.

Exploring Serum Biomarkers for Mild Traumatic Brain Injury.

Papa L, Edwards D, Ramia M.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 22.

10.

Intracellular gene transcription factor protein-guided MRI by DNA aptamers in vivo.

Liu CH, Ren J, Liu CM, Liu PK.

FASEB J. 2014 Jan;28(1):464-73. doi: 10.1096/fj.13-234229.

11.
12.

Magnetic resonance imaging of iron deposition in neurological disorders.

Brass SD, Chen NK, Mulkern RV, Bakshi R.

Top Magn Reson Imaging. 2006 Feb;17(1):31-40. Review.

PMID:
17179895
13.

Reporter gene imaging: potential impact on therapy.

Serganova I, Blasberg R.

Nucl Med Biol. 2005 Oct;32(7):763-80. Review.

PMID:
16243653
14.

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease.

Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Greve DN, Salat DH, Buckner RL, Fischl B; Alzheimer's Disease Neuroimaging Initiative..

Brain. 2009 Aug;132(Pt 8):2048-57. doi: 10.1093/brain/awp123.

15.
16.

Development and applications of in vivo clinical magnetic resonance spectroscopy.

Cox IJ.

Prog Biophys Mol Biol. 1996;65(1-2):45-81. Review.

PMID:
9029941
17.

PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity studies.

Liu Y, Yang K, Cheng L, Zhu J, Ma X, Xu H, Li Y, Guo L, Gu H, Liu Z.

Nanomedicine. 2013 Oct;9(7):1077-88. doi: 10.1016/j.nano.2013.02.010.

PMID:
23499668
18.

Perfusion magnetic resonance imaging in psychiatry.

Théberge J.

Top Magn Reson Imaging. 2008 Apr;19(2):111-30. doi: 10.1097/RMR.0b013e3181808140. Review.

PMID:
19363433
19.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly..

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. French.

PMID:
19748369
20.

Protein targeting in the analysis of learning and memory: a potential alternative to gene targeting.

Gerlai R, Williams SP, Cairns B, Van Bruggen N, Moran P, Shih A, Caras I, Sauer H, Phillips HS, Winslow JW.

Exp Brain Res. 1998 Nov;123(1-2):24-35.

PMID:
9835389

Supplemental Content

Support Center